Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive and Nonradioactive

OLINDA/EXM 2.0: The new generation dosimetry modeling code

Michael Stabin and Adam Farmer
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 585;
Michael Stabin
1Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Farmer
1Vanderbilt University, Nashville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

585

Objectives The OLINDA/EXM code developed by the RAdiation Dose Assessment Resource (RADAR) Task Group of the Society of Nuclear Medicine has standardized dose calculations for diagnostic and therapeutic radiopharmaceuticals. The previous generation of anthropomorphic phantoms were based on the Oak Ridge models, which employed geometrical shapes to define the body and its organs. These models have been replaced with realistic, NURBS-type models based on the recent standardized masses defined by the ICRP in its publication 89. These and other new models have been implemented in a new version of the OLINDA/EXM code.

Methods The realistic adult, pediatric, and pregnant female phantom series were used in Monte Carlo simulations to produce organ specific absorbed fractions (SAFs). These values were used with recently released decay data to produce organ dose factors (DFs), which are used by the code. Updated techniques and data for modeling the kinetics of the gastrointestinal tract, gender averaging of dose, and calculation of effective dose were also implemented in the code. The code remains in the Java environment, although its structure was reorganized. The ability to automatically combine results for multiple nuclides (e.g. from a decay series) was added.

Results The code remains user-friendly and easy to use. Numerical results are not significantly different from those based on the previous generation of phantoms, although some adjustments in understanding of doses to the GI tract, as proposed by the ICRP, will be needed. The ability to calculate doses to eyes, esophagus, salivary glands, and the prostate gland, and implementation of the new effective dose weighting factors represent a significant advance. Previous phantoms and effective dose weighting factors were retained for comparisons.

Conclusions The new generation of models is now available in the OLINDA/EXM code, and represents a significant improvement in standardized dose calculations

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
OLINDA/EXM 2.0: The new generation dosimetry modeling code
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
OLINDA/EXM 2.0: The new generation dosimetry modeling code
Michael Stabin, Adam Farmer
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 585;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
OLINDA/EXM 2.0: The new generation dosimetry modeling code
Michael Stabin, Adam Farmer
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 585;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive and Nonradioactive

  • A radioactive method for assessing microbial safety of an infusion set for contrast-enhanced imaging
  • Cathepsin K inhibitors for in vivo osteoclast imaging by PET
  • Radiosynthesis of 64Cu-labelled cetuximab for clinical use
Show more Molecular Targeting Probes - Radioactive and Nonradioactive

Dosimetry & Image Analysis

  • Application of 18F-NaF-PET/CT in assessing age-related changes in the cervical spine of healthy adults
  • Voxel-wise preclinical dosimetry of 177Lu-NM600 using the Monte Carlo-based dosimetry platform RAPID
  • Evaluation of therapeutic alpha emitters for their potential to be used in FAPI compounds
Show more Dosimetry & Image Analysis

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire